Pubblicazioni

1) G. Tedeschi, A. Bertolino, A. Righini, G. Campbell, R. Raman, J.H. Duyn, C.T.W. Moonen, J.R. Alger, G. Di Chiro: Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 1995;45:1384-1391
2) G. Tedeschi, A. Bertolino, N Lundbom, S Bonavita, TN Chase, NJ Patronas, L Verhagen, G Di Chiro: Regional distribution pattern of cortical and subcortical pathology in Alzheimer’s disease as assessed by multslice proton magnetic resonance spectroscopic imaging. Neurology 1996;47:696-704
3) G. Tedeschi, A. Bertolino, S. Massaquoi, G. Campbell, N.J. Patronas, S. Bonavita, A.S. Barnett, J.R. Alger, M. Hallett. Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration. Ann Neurol 1996; 39:71-78
4) A Bertolino, S. Nawroz, V.S. Mattay, J.H. Duyn, C.T.W. Moonen, A.S. Barnett, J.A. Frank, G. Tedeschi, D.R. Weinberger: “A specific pattern of impaired neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging” Am J Psychiatry 1996;153:1554-1563
5) G. Tedeschi, A. Bertolino, G. Campbell, A.S. Barnett, PK Jacob, CTW Moonen, JH Duyn, JR Alger, G Di Chiro: Reproducibility of proton magnetic resonance spectroscopic imaging. Am J Neuroradiology 1996;17:1871-1879
6) A Bertolino, D.R. Weinberger. Neuroimaging in schizophrenia: a neurodevelopmental perspective for the involvement of frontal and temporo-limbic cortex. Italian Journal of Psychopathology 1996;3:201-207
7) G. Tedeschi, I. Litvan, S. Bonavita, A. Bertolino, N. Lundbom, N.J. Patronas, G. Di Chiro: Proton Magnetic Resonance Spectroscopic Imaging in progressive supranuclear palsy, Parkinson’s disease, and corticobasal degeneration.” Brain 1997;120:1541-1552
8) VS Mattay, JH Callicott, A Bertolino, AKS Santha, KA Tallent, TE Goldberg, JA Frank, DR Weinberger: Abnormal Functional Lateralization of the Sensorimotor Cortex in Patients with Schizophrenia. Neuroreport 1997;8:2977-2984
9) A Bertolino, Weinberger DR: Fisiopatologia della schizofrenia e sviluppo del cervello. Problemi in Psichiatria 1997;12:5-12
10) J.H. Callicott, N. Ramsey, K. Tallent, A. Bertolino, M.B. Knable, R. Coppola, T.E. Goldberg, P. van Gelderen, V.S. Mattay, J.A. Frank, C.T.W. Moonen, D.R. Weinberger: Functional Magnetic Resonance Imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 1998:18;186-196.
11) A Bertolino, J.H. Callicott, S. Nawroz, V.S. Mattay, J.H. Duyn, G. Tedeschi, J.A. Frank, D.R. Weinberger: Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacology 1998:18;1-9.
12) A Bertolino, J.H. Callicott, I. Elman, V.S. Mattay, J.H. Duyn, G. Tedeschi, J.A. Frank, A. Breier, D.R. Weinberger: Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 1998:43;641-648.
13) A Bertolino, R.C. Saunders, V.S. Mattay, J. Bachevalier, J.A. Frank, D.R. Weinberger: Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. Cerebral Cortex 1997:7;740-748.
14) A Bertolino, S. Kumra, JH Callicott, VS Mattay, RM Lestz, L Jacobsen, AS Barnett, JH Duyn, JA Frank, JL Rapoport, DR Weinberger: Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1998;155:1376-1383.
15) JH Callicott, MF Egan, A Bertolino, VS Mattay, FJP Langheim, JA Frank, DR Weinberger: Hippocampal N-acetylaspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biol Psychiatry 1998;44:941-950.
16) VS Mattay, JH Callicott, A Bertolino, AK Santha, JD Van Horn, KA Tallent, JA Frank, DR Weinberger: Hemispheric control of motor function: a whole brain echo planar fMRI study. Psychiatry Research: Neuroimaging 1998 Jul 15;83(1):7-22.
17) JH Callicott, VS Mattay, A Bertolino, K Finn, R Coppola, JA Frank, TE Goldberg, DR Weinberger:Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cerebral Cortex. 1999;9(1):20-6.
18) A Bertolino, MB Knable, RC Saunders, JH Callicott, B Kolachana, VS Mattay, J Bachevalier, JA Frank, M Egan, DR Weinberger: The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry 1999 Mar 15;45(6):660-7.
19) A Bertolino, DR Weinberger: Proton magnetic resonance spectroscopy in schizophrenia. Eur J Radiology 1999;30:132-141.
20) T Scarabino, T Popolizio, A Bertolino, U Salvolini: Proton magnetic resonance spectroscopy of the brain in pediatric patients. Eur J Radiology 1999;30:142-153.
21) A Bertolino: Dysregulation of dopamine and pathology of prefrontal neurons: neuroimaging studies in schizophrenia and related animal models. Epidemiologia e Psichiatria Sociale. 1999;8(4):248-54.
22) A Bellomo, A Bertolino, D Labriola, M Nardini: The psychopathology of dementia and of depression with late-life onset. Psychiatric Networks 1999;2(2):38-49
23) A Bertolino, G Esposito, JH Callicott, VS Mattay, JD Van Horn, JA Frank, KF Berman, DR Weinberger: Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 2000 Jan;157(1):26-33.
24) A Bertolino, A Breier, JH Callicott, C Adler, VS Mattay, M Shapiro, JA Frank, D Pickar, DR Weinberger: The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology 2000;22(2):125-32.
25) JL Roffman, BK Lipska, A Bertolino, P Van Gelderen, AW Olson, ZZ Khaing, DR Weinberger: Local and downstream effects of excitotoxic lesions in the rat medial prefrontal cortex on In vivo 1H-MRS signals. Neuropsychopharmacology 2000; 22(4):430-9.
26) VS Mattay, JH Callicott, A Bertolino, I Heaton, JA Frank, R Coppola, KF Berman, TE Goldberg, DR Weinberger: Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage 2000;12,268-275
27) A Bertolino, JH Callicott, VS Mattay, R Rakow, KW Weidenhammer, DR Weinberger: The effect of treatment with antipsychotic drugs on brain N-
acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 2001 Jan 1;49(1):39-46
28) JH Callicott, A Bertolino, MF Egan, VS Mattay, FJP Langheim, DR Weinberger: Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. Am J Psychiatry 2000;157:1646-1651
29) JH Callicott, A Bertolino, VS Mattay, FJP Langheim, JH Duyn, RC Coppola, TE Goldberg, DR Weinberger: Physiological dysfunction of the prefrontal cortex in schizophrenia revisited. Cerebral Cortex 2000;10(11):1078-1092
30) M Altamura, M Pepe, A Tafaro, I Munno, A Bertolino, D Labriola, A Vacca, E Jirillo, M Nardini A syndrome characterized by psychiatric disorders, recurrent mucosal infections and natural immunity deficits: Clinical approach. Immunopharmacology and Immunotoxicology 23: (2) 303-306 2001
31) A Bertolino, F Brudaglio, M Nardini: Pathophysiology of schizophrenia and the neurodevelopmental hypothesis: evidence from an animal model. Psychiatric Networks 3(2):10-21;2000.
32) A Bertolino, J Roffman, B Lipska, P van Gelderen, A Olson, DR Weinberger: Reduced N-acetylaspartate in prefrontal cortex of adult rats with neonatal hippocampal damage. Cerebral Cortex 2002;12:983-990
33) DR Weinberger, MF Egan, A Bertolino, JH Callicott, VS Mattay, BK Lipska, KF Berman, TE Goldberg: Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001 Dec 1;50(11):825-44
34) VS Mattay, A Tessitore, JH Callicott, A Bertolino, TE Goldberg, TN Chase, TM Hyde, DR Weinberger: Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 2002 Feb;51(2):156-64
35) A Bertolino, D Sciota, F Brudaglio, M Altamura, G Blasi, A Bellomo, N Antonucci, J H. Callicott, T E. Goldberg, T Scarabino, D R. Weinberger, M Nardini: Working memory deficits and levels of n-acetylaspartate in patients with schizophreniform disorder.“ Am J Psychiatry, March 2003 160: 483-489
36) A Bertolino, M Frye, J H Callicott, V S Mattay, R Rakow, J Shelton-Repella, R Post, D R Weinberger: Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003;53:906-913
37) MF Egan, M Kojima, JH Callicott, TE Goldberg, BS Kolachana, A Bertolino, E Zaitsev, B Gold, D Goldman, M Dean, B Lu, DR Weinberger: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003 Jan 24;112(2):257-69.
38) JH Callicott, MF Egan, VS Mattay, A Bertolino, AD Bone, B Verchinksi, DR Weinberger: Abnormal fMRI Response of the Dorsolateral Prefrontal Cortex in Cognitively Intact Siblings of Patients With Schizophrenia Am J Psychiatry 2003 Apr;160(4):709-19.
39) T Scarabino, F Nemore, GM Giannatempo, A Bertolino, F Di Salle, U Salvolini: 3.0 T magnetic resonance in neuroradiology. Eur J Radiol. 2003 Nov;48(2):154-64.
40) T Scarabino, A Bertolino, M Burroni, T Popolizio, JH Duyn, DR Weinberger, U Salvolini: White Matter Lesions in Phenylketonuria: evaluation with magnetic resonance imaging and magnetic resonance spectroscopy. Riv Neuroradiologia 16:251-262, 2003
41) G Blasi, A Bertolino, F Brudaglio, D Sciota, M Altamura, N Antonucci, T Scarabino, DR Weinberger, M Nardini: Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a Proton Magnetic Resonance Spectroscopic Imaging Study. Psychiatry Research-Neuroimaging 2004 131:195-205;2004
42) A Bertolino, G Caforio, G Blasi, MP De Candia, V Latorre, V Petruzzella, M Altamura, G Nappi, S Papa, JH Callicott, VS Mattay, A Bellomo, T Scarabino, DR Weinberger, M Nardini: Interaction of COMT Val108/158 Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 2004, 161:1798-1805;2004
43) A Bertolino, G Blasi, G Caforio, V Latorre, MP De Candia, V Rubino, JH Callicott, VS Mattay, A Bellomo, T Scarabino, DR Weinberger, M Nardini: Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine. Biol Psychiatry, 56(3):190-197;2004
44) MF Egan, RE Straub, TE Goldberg, I Yakub, JH Callicott, AR Hariri, A Bertolino, TM Hyde, C Shannon-Weickert, M Akil, J Crook, R Vakkalanka, R Balkissoon, RA Gibbs, JE Kleinman, DR Weinberger. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. PNAS 101(34):12604-12609; 2004.
45) A Bertolino, G Arciero, V Rubino, V Latorre, MP De Candia, V Mazzola, G Blasi, G Caforio, AR Hariri, B Kolachana, M Nardini, DR Weinberger, T Scarabino. Variation of human amygdala response during threatening stimuli as a function of 5’HTTLPR genotype and personality style. Biol Psychiatry. 2005 Jun 15;57(12):1517-25.
46) G Blasi, VS Mattay, A Bertolino, B Elvevåg, JH Callicott, S Das, B Kolachana, MF Egan, TE Goldberg, DR Weinberger: Effect of Catechol-O -methyltransferase val158met genotype on attentional control. J Neurosci. 2005 May 18;25(20):5038-45.
47) G Blasi, A Bertolino: Imaging genomics and response to treatment with antipsychotics in schizophrenia. NeuroRx. 2006 Jan;3(1):117-30.
48) G Blasi, TE Goldberg, T Weickert, S Das, P Kohn, B Zoltick, A Bertolino, JH Callicott, DR Weinberger, VS Mattay: Brain regions underlying response inhibition and interference monitoring and suppression. Eur J Neuroscience 2006 Mar;23(6):1658-1664
49) A Bertolino, G Blasi, V Latorre, V Rubino, A Rampino, L Sinibaldi, G Caforio, V Petruzzella, A Pizzuti, T Scarabino, M Nardini, DR Weinberger, B Dallapiccola: Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci, 2006 Apr 12;26(15):3918-22.
50) S. Marenco, A. Bertolino, D.R. Weinberger. In vivo NMR measures of NAA and the neurobiology of schizophrenia. ADV EXP MED BIOL 576: 227-240 2006
51) G Blasi, TE Goldberg, B Elvevåg, R Rasetti, A Bertolino, J Cohen, G Alce, B Zoltick, DR Weinberger, VS Mattay: Differentiating control and conflict management within attentional processing. Eur J Neurosci. 2007 Jan;25(2):594-602.
52) A Bertolino, V Rubino, F Sambataro, G Blasi, V Latorre, L Fazio, G Caforio, V Petruzzella, B Kolachana, A Hariri, A Meyer-Lindenberg, M Nardini, DR Weinberger, T Scarabino. Prefrontal-hippocampal coupling during declarative memory is modulated by COMT Val158Met genotype. Biol Psychiatry 2006;60:1250–1258
53) G. Blasi, A. Bertolino: “The use of functional imaging to evaluate the neurobiology of putative schizophrenia susceptibility genes”. Advances in Schizophrenia and Clinical Psychiatry, 2006, 2 (4): 128-135.
54) A Bertolino, G Caforio, V Petruzzella, V Latorre, V Rubino, S Dimalta, A Torraco, G Blasi, R Quartesan, VS Mattay, JH Callicott, DR Weinberger, T Scarabino. Prefrontal dysfunction in schizophrenia controlling for COMT val158met genotype and working memory performance. Psychiatry Research: Neuroimaging, 2006 Oct 30;147(2-3):221-6.
55) F Esposito, A Bertolino, T Scarabino, V Latorre, G Blasi, T Popolizio, G Tedeschi, S Cirillo, R Goebel, F Di Salle: Independent Component Model of the Default-mode Brain Function: Assessing the Impact of Active Thinking, Brain Research Bulletin, 2006 Oct 16;70(4-6):263-9.
56) F Sambataro, S Dimalta, T Scarabino, A Di Giorgio, P Taurisano, G Blasi, M Nardini, A Bertolino. Preferential responses in amygdala and insula during presentation of facial contempt and disgust. European Journal of Neuroscience, 2006 Oct;24(8):2355-62.
57) A Bertolino, G Caforio, G Blasi, A Rampino, L Sinibaldi, S Douzgou, M Nardini, DR Weinberger, B Dallapiccola. COMT Val158Met predicts negative symptoms response
to treatment with olanzapine in schizophrenia. Schizophrenia Research, 2007; 95: 253–255
58) M Altamura, B Elvevåg, G Blasi, A Bertolino, JH Callicott, DR Weinberger, VS Mattay, TE Goldberg: “Dissociating the Effects of Sternberg Working Memory Demands in Prefrontal Cortex.” Psychiatry Research: Neuroimaging, 2007 Feb 28;154(2):103-14
59) V Rubino, G. Blasi, V Latorre, L Fazio, Immacolata D’Errico, Viridiana Mazzola, Grazia Caforio, Marcello Nardini, Teresa Popolizio, Ahmad Hariri, Giampiero Arciero, Alessandro Bertolino: “Activity in medial prefrontal cortex during cognitive evaluation of threatening stimuli as a function of personality style.” Brain Research Bulletin, 2007; Sep 28;74(4):250-7.
60) Y. Zhang, A. Bertolino, L. Fazio, G. Blasi, A. Rampino, R. Romano, ML Lee, T. Xiao, A. Papp, D. Wang, W. Sadee: “Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory”. Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20552-7. Epub 2007 Dec 11.
61) A. Bertolino, A. Di Giorgio, G. Blasi, F. Sambataro, G. Caforio, L. Sinibaldi, V. Latorre, A. Rampino, P. Taurisano, L. Fazio, R. Romano, S. Douzgou, B. Kolachana, M. Nardini, D.R. Weinberger, B. Dallapiccola: “Epistasis between dopamine regulating genes identifies a non-linear response of the human hippocampus during memory tasks”. Biological Psychiatry 2008 Aug 1;64(3):226-34. Mar 27 [Epub ahead of print].
62) A. Bertolino, L. Fazio, G. Caforio, G. Blasi, A. Rampino, R. Romano, A. Di Giorgio, P. Taurisano, A. Papp, J. Pinsonneault, D. Wang, M. Nardini, T. Popolizio, W. Sadee. Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain. 2009 Feb;132(Pt 2):417-25. Epub 2008 Oct 1.
63) A Bertolino, L Fazio, A Di Giorgio, G Blasi, R Romano, P Taurisano, G Caforio, L Sinibaldi, G Ursini, T Popolizio, E Tirotta, A Papp, B Dallapiccola, E Borrelli, W Sadee. Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. Journal of Neuroscience January 28, 2009 • 29(4):1224 –1234
64) A. Di Giorgio, F. Sambataro, A. Bertolino. Functional Imaging as a Tool to Investigate the Relationship between Genetic Variation and Response to Treatment with Antipsychotics. Current Pharmaceutical Design, 2009, 15, 2560-2572
65) R Zanardi, B Barbini, D Rossini, A Bernasconi, F Fregni, F Padberg, S Rossi, A Wirz-Justice, M Terman, K Martiny, G Bersani, AR Hariri, L Pezawas, JP Roiser, A Bertolino, G Calabrese, L Magri,F Benedetti, A Pontiggia, A Malaguti, E Smeraldi, C Colombo. New perspectives on techniques for the clinical psychiatrist: Brain stimulation, chronobiology and psychiatric brain imaging. Psychiatry Clin Neurosci. 2008 Dec;62(6):627-37.
66) S Huffaker, J Chen, KK Nicodemus, F Sambataro, F Yang, VS Mattay, BK Lipska, TM Hyde, J Song, D Rujescu, I Giegling, K Mayilyan, A Soghoyan, G Caforio, A Bertolino, A Meyer-Lindenberg, J Chang, M Egan, TE Goldberg, JE Kleinman, B Lu, DR Weinberger. A novel, primate-specific brain isoform of KCNH2: Role in hippocampal biology, neuronal repolarization, cognition, and association with schizophrenia. Nature Medicine, 2009 May;15(5):509-18. Epub 2009 May 3
67) A Bertolino, G Blasi: The genetics of schizophrenia. Neuroscience. 2009 Nov 24;164(1):288-99. Epub 2009 Apr 22.
68) G Blasi, T Popolizio, P Taurisano, G Caforio, R Romano, A Di Giorgio, F Sambataro, V Rubino, V Latorre, L Lo Bianco, L Fazio, M Nardini, DR Weinberger, A Bertolino. Changes in prefrontal and amygdala activity during olanzapine treatment in schizophrenia. Psychiatry Res. 2009 Jul 15;173(1):31-8. Epub 2009 May 9.
69) G Blasi, AH Hariri, G Alce, P Taurisano, F Sambataro, A Bertolino, DR Weinberger, VS Mattay. Preferential amygdala reactivity to the negative assessment of neutral faces, Biological Psychiatry, 2009 Nov 1;66(9):847-53. Epub 2009 Aug 26.
70) G Blasi, P Taurisano, A Papazacharias, G Caforio, R Romano, L Lobianco, L Fazio, A Di Giorgio, V Latorre, F Sambataro, T Popolizio, M Nardini, VS Mattay, DR Weinberger, A Bertolino. Non-linear response of the anterior cingulate and prefrontal cortex in schizophrenia as a function of variable attentional control. Cerebral Cortex, 2010 Apr;20(4):837-45. Epub 2009 Jul 24.
71) S Pini, M Abelli, KM Shear, A Nardini, L Lari, C Gesi, M Muti, S Calugi, S Galderisi, A Troisi, A Bertolino, GB Cassano. Frequency and clinical correlates of adult separation anxiety in a sample of 508 outpatients with mood and anxiety disorders. Acta Psychiatrica Scandinavica 2009 Oct 13. [Epub ahead of print]
72) F Sambataro, G Blasi, L Fazio, G Caforio, P Taurisano, R Romano, A Di Giorgio, B Gelao, L Lobianco, A Papazacharias, T Popolizio, M Nardini, A Bertolino. Treatment with olanzapine is associated with modulation of the default mode network in patients with schizophrenia. Neuropsychopharmacology, 2010 Mar;35(4):904-12. Epub 2009 Dec 2.
73) G Blasi, L Lo Bianco, P Taurisano, B Gelao, R Romano, L Fazio, A Papazacharias, A Di Giorgio, G. Caforio, A. Rampino, R Masellis, A Papp, G Ursini, L Sinibaldi, T Popolizio, W Sadee, A Bertolino. Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans. Journal of Neuroscience, 2009 Nov 25;29(47):14812-9
74) A Bertolino, P Taurisano, NM Pisciotta, G Blasi, L Fazio, R Romano, B Gelao, L Lo Bianco, M Lozupone, A Di Giorgio, G Caforio, F Sambataro, A Niccoli-Asabella, A Papp, G Ursini, L Sinibaldi, T Popolizio, W Sadee, G Rubini. Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS ONE, 2010 Feb 22;5(2):e9348.
75) A Di Giorgio, G Caforio, G Blasi, P Taurisano, L Fazio, R Romano, GL Ursini, B Gelao, L Lo Bianco, A Papazacharias, L Sinibaldi, T Popolizio, A Bellomo, A Bertolino. Catechol-O-Methyltransferase Val158Met association with parahippocampal physiology during memory encoding in schizophrenia. Psychol Med. 2010 Dec 13:1-11. [Epub ahead of print]
76) L Fazio, G Blasi, P Taurisano, A Papazacharias, R Romano, B Gelao, GL Ursini, T Quarto, L Lo Bianco, A Di Giorgio, M Mancini, T Popolizio, G. Rubini. D2 receptor genotype and striatal dopamine signaling predict motor cortical activity and behavior in humans. Neuroimage. 2011 Feb 14;54(4):2915-21. Epub 2010 Nov 16.
77) G Blasi, F Napolitano, G Ursini, P Taurisano, R Romano, G Caforio, L Fazio, B Gelao, A Di Giorgio, L Iacovelli, L Sinibaldi, T Popolizio, A Usiello, A Bertolino DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing and response to olanzapine treatment in schizophrenia. Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1158-63. Epub 2010 Dec 27.
78) JK Pinsonneault, D Han, M Kataki, A Bertolino, AK Malhotra, H Gu, W Sadee. A dopamine transporter gene variant that affects expression in human brain and associates with bipolar disorder. Neuropsychopharmacology. 2011 Jul;36(8):1644-55. Epub 2011 Apr 27.
79) D Martino, A Di Giorgio, E D’Ambrosio, T Popolizio, A Macerollo, P Livrea, A Bertolino, G Defazio. Cortical gray matter changes in primary blepharospasm: a voxel-based morphometry study. Mov Disord 2011 Jun 29. [Epub ahead of print].
80) F Sambataro, L Fazio, P Taurisano, B Gelao, A Porcelli, M Mancini, L Sinibaldi, G Ursini, R Masellis, G Caforio, A Di Giorgio, A Niccoli-Asabella, T Popolizio, G Blasi, A Bertolino. DRD2 genotype based variation of default mode network activity and of its relationship with striatal DAT binding. Schizophr Bull. 2011 Oct 5. [Epub ahead of print]
81) Ursini G, Bollati V, Fazio L, Porcelli A, Iacovelli L, Catalani A, Sinibaldi L, Gelao B, Romano R, Rampino A, Taurisano P, Mancini M, Di Giorgio A, Popolizio T, Baccarelli A, De Blasi A, Blasi G, Bertolino A. Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J Neurosci. 2011 May 4;31(18):6692-8.
82) L Lo Bianco L, G Blasi, P Taurisano, A Di Giorgio, F Ferrante, G Ursini, L Fazio, Barbara Gelao, R Romano, A Papazacharias, G Caforio, L Sinibaldi, T Popolizio, C Bellantuono, A Bertolino: Interaction between Comt Val158Met genotype and genetic
vulnerability to schizophrenia during explicit processing of aversive facial stimuli. Psychol Med. 2012 May 23:1-14. [Epub ahead of print]
83) G Vecchione, B Casetta, A Chiapparino, A Bertolino, M Tomaiuolo, F Cappuccia, R Gatta, M Margaglione, E Grandone, A reliable and rapid tool for plasma quantification of 18 psychotropic drugs by ESI tandem mass spectrometry. J Pharm Biomed Anal. 2012 Aug-Sep;67-68:104-13. Epub 2012 Apr 26.
84) A Di Giorgio, B Gelao, G Caforio, R Romano, I Andriola, E D'Ambrosio, A Papazacharias, F Elifani, L Lo Bianco, P Taurisano, L Fazio, T Popolizio, G Blasi, A Bertolino. Evidence that hippocampal-parahippocampal dysfunction is related to genetic risk for schizophrenia. Psychol Med. 2012 Oct 31:1-11. [Epub ahead of print]
85) M Altamura, L Fazio, M De Salvia, A Petito, G Blasi, P Taurisano, R Romano, B Gelao, A Bellomo, A Bertolino. Abnormal functional motor lateralization in healthy siblings of patients with schizophrenia. Psychiatry Res. 2012 Jul 30;203(1):54-60. Epub 2012 Aug 15.
86) P Taurisano, G Blasi, R Romano, F Sambataro, L Fazio, B Gelao, G Ursini, L Lo Bianco, A Di Giorgio, F Ferrante, A Papazacharias, A Porcelli, L Sinibaldi, T Popolizio, A Bertolino. DAT by perceived MC interaction on human prefrontal activity and connectivity during emotion processing. Soc Cogn Affect Neurosci. 2012 Sep 30. [Epub ahead of print]
87) G Blasi, C De Virgilio, A Papazacharias, P Taurisano, B Gelao, L Fazio, G Ursini, L Sinibaldi, I Andriola, R Masellis, R Romano, A Rampino, A Di Giorgio, L Lo Bianco, G Caforio, Francesco Piva, T Popolizio, C Bellantuono, O Todarello, JE Kleinman, G Gadaleta, DR Weinberger, A Bertolino. Converging evidence for the association of functional genetic variation in HTR2A with prefrontal physiology and olanzapine treatment. JAMA Psychiatry. 2013 Sep;70(9):921-30. doi: 10.1001/jamapsychiatry.2013.1378. PubMed PMID: 23842608.
88) G Blasi, F Napolitano, G Ursini, A Di Giorgio, G Caforio, P Taurisano, L Fazio, B Gelao, MT Attrotto, L Colagiorgio, G Todarello, F Piva, A Papzacharias, R Masellis, M Mancini, A Porcelli, R Romano, A Rampino, T Quarto, M Giulietti, BK Lipska, JE Kleinman, T Popolizio, DR Weinberger, A Usiello, A Bertolino. GSK-3β genetic variation is associated with GSK-3βexpression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia. Am J Psychiatry, 2013 Aug 1;170(8):868-76. doi: 10.1176/appi.ajp.2012.12070908.
89) F Errico, F Napolitano, M Squillace, D Vitucci, G Blasi, A de Bartolomeis, A Bertolino, A D’Aniello, A Usiello. Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia. Psychiatr Res. 2013 Jul 6. doi:pii: S0022-3956(13)00196-9. 10.1016/j.jpsychires.2013.06.013. [Epub ahead of print]
90) G Caforio, A Di Giorgio, A Rampino, M Rizzo, R Romano, P Taurisano, L Fazio, G De Simeis, G Ursini, G Blasi, M Nardini, M Mancini, A Bertolino. Mirtazapine add-
on improves olanzapine effect on negative symptoms of schizophrenia. J Clin Psychopharmacol. 2013 Dec;33(6):810-2. doi: 10.1097/JCP.0b013e3182a4ec77
91) C Tortorella, R Romano, V Direnzo, P Taurisano, S Zoccolella, P Iaffaldano, L Fazio, R Viterbo, T Popolizio, G Blasi, A Bertolino, M Trojano. Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler. 2013 Aug;19(9):1153-60. doi: 10.1177/1352458512473671. Epub 2013 Jan 17
92) B Gelao, L Fazio, P Selvaggi, A Di Giorgio, P Taurisano, T Quarto, R Romano, A Porcelli, M Mancini, R Masellis, G Ursini, G De Simeis, G Caforio, L Ferranti, L Lo Bianco, A Rampino, O Todarello, T Popolizio, G Blasi, A Bertolino. DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine. Psychopharmacology, (2014) 231:2361–2370
93) G Todarello, N Feng, BS Kolachana, C Li, R Vakkalanka, A Bertolino, DR Weinberger, RE Straub. Incomplete penetrance of NRXN1 deletions in families with schizophrenia. Schizophr Res. 2014 May;155(1-3):1-7. doi: 10.1016/j.schres.2014.02.023. Epub 2014 Mar 26.
94) A Di Giorgio, RM Smith, L Fazio, B Gelao, A Tomasicchio, P Selvaggi, P Taurisano, T Quarto, R Masellis, A Rampino, G Caforio, T Popolizio, G Blasi, W Sadee, A Bertolino. DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory. PLoS ONE, 2014; 9(5): e95997. doi:10.1371/journal.pone.0095997
95) P Taurisano, R Romano, M Mancini, A Di Giorgio, L Antonucci, L Fazio, A Rampino, T Quarto, B Gelao, A Porcelli, A Papazacharias, G Ursini, G Caforio, R Masellis, A Niccoli-Asabella, O Todarello, T Popolizio, G Rubini, G Blasi, A Bertolino. Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2. Front Behav Neurosci. 2014 Jul 9;8:235. doi: 10.3389/fnbeh.2014.00235. eCollection 2014.
96) F Errico, R Nisticò, A Di Giorgio, M Squillace, D Vitucci, A Galbusera, S Piccinin, D Mango, L Fazio, NB Mercuri, S Middei, S Trizio, D Centonze, A Gozzi, G Blasi, A Bertolino#, A Usiello. Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, grey matter volume and brain activity in mammals. Transl Psychiatry. 2014 Jul 29;4:e417. doi: 10.1038/tp.2014.59. #co-corresponding author
97) A Rampino, RM Walker, HS Torrance, S Maguire Anderson, L Fazio, A Di Giorgio, P Taurisano, B Gelao, R Romano, R Masellis, G Ursini, G Caforio, G Blasi, J. Kirsty Millar, DJ Porteous, PA Thomson, A Bertolino#, KL Evans. Expression of DISC1-Interactome Members Correlates with Cognitive Phenotypes Related to Schizophrenia PLoS One. 2014 Jun 18;9(6):e99892. doi: 10.1371/journal.pone.0099892. eCollection 2014. #co-corresponding author
98) T Quarto, G Blasi, KJ Pallesen, A Bertolino, E Brattico. Implicit processing of visual emotions is affected by sound-induced affective states and individual affective traits.
PLoS One. 2014 Jul 29;9(7):e103278. doi: 10.1371/journal.pone.0103278. eCollection 2014.
99) R Romano R, A Bertolino, A Gigante, D Martino, P Livrea, G Defazio. Impaired cognitive functions in adult-onset primary cranial cervical dystonia. Parkinsonism Relat Disord. 2014 Feb;20(2):162-5. doi: 10.1016/j.parkreldis.2013.10.008. Epub 2013 Oct 17.
100) M Colizzi, L Fazio, L Ferranti, A Porcelli, R Masellis, D Marvulli, A Bonvino, G Ursini, G Blasi, A Bertolino. Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior. Neuropsychopharmacology. 2015 Feb;40(3):640-9. doi:10.1038/npp.2014.213. Epub 2014 Aug 20.
101) C Tortorella, V Direnzo, P Taurisano, R Romano, M Ruggieri, S Zoccolella, M Mastrapasqua, T Popolizio, G Blasi, A Bertolino and M Trojano. Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis. Multiple Sclerosis Journal 2014 Aug 28. pii: 1352458514546789. [Epub ahead of print]
102) S Galderisi, A Rossi, P Rocca, A Bertolino, A Mucci, P Bucci, P Rucci, D Gibertoni, E Aguglia, M Amore, A Bellomo, M Biondi, R Brugnoli, L Dell'Osso, D De Ronchi, G Di Emidio, M Di Giannantonio, A Fagiolini, C Marchesi, P Monteleone, L Oldani, F Pinna, R Roncone, E Sacchetti, P Santonastaso, A Siracusano, A Vita, P Zeppegno, M Maj; Italian Network For Research on Psychoses. The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry. 2014 Oct;13(3):275-87. doi: 10.1002/wps.20167.
103) J Dukart, A Bertolino. When structure affects function - the need for partial volume effect correction in functional and resting state magnetic resonance imaging studies. PLoS ONE (2014) (12): e114227. doi:10.1371/journal.pone. 0114227
104) A Mucci, P Rucci, P Rocca, P Bucci P, D Gibertoni, E Merlotti, S Galderisi, M Maj; Italian Network for Research on Psychoses. The Specific Level of Functioning Scale: construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community. Schizophr Res. 2014 Oct;159(1):144-50. doi: 10.1016/j.schres.2014.07.044. Epub 2014 Aug 30.
105) G Blasi, P Selvaggi, L Fazio, L Antonucci, P Taurisano, R Masellis, R Romano, M Mancini, F Zhang, G Caforio, T Popolizio, J Apud, DR Weinberger, A Bertolino. Variation in dopamine D2 and serotonin 5-HT2A receptor genes is associated with working memory processing and response to treatment with antipsychotics. Neuropsychopharmacology. 2015 Jan 7. doi: 10.1038/npp.2015.5. [Epub ahead of print]
106) G Pergola, P Selvaggi, S Trizio, A Bertolino, G Blasi. The role of the thalamus in schizophrenia from a neuroimaging perspective. Neurosci Biobehav Rev. 2015 Jan 20. pii: S0149-7634(15)00015-9. doi: 10.1016/j.neubiorev.2015.01.013. [Epub ahead of print] Review.
107) F Errico, V D'Argenio, F Sforazzini, F Iasevoli, M Squillace, G Guerri, F Napolitano, T Angrisano, A Di Maio, S Keller, D Vitucci, A Galbusera, L Chiariotti, A Bertolino, A de Bartolomeis, F Salvatore, A Gozzi, A Usiello. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice. Transl Psychiatry. 2015 Feb 17;5:e512. doi: 10.1038/tp.2015.2.
108) M Colizzi, C Iyegbe, J Powell, GL Ursini, A Porcelli, A Bonvino, P Taurisano, R Romano, R Masellis, G Blasi, C Morgan, K Aitchison, V Mondelli, S Luzi, A Kolliakou, RM Murray, A Bertolino, M Di Forti. Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis. Schizophrenia Bulletin, 2015 Mar 31. pii: sbv032. [Epub ahead of print]
109) B Dell’Osso, C Cinnante, A Di Giorgio, L Cremaschi, MC Palazzo, M Cristoffanini, L Fazio, C Dobrea, S Avignone, F Triulzi, A Bertolino, AC Altamura. Altered prefrontal cortex activity during working memory task in Bipolar Disorder: a functional magnetic resonance imaging study in euthymic bipolar I and II patients. J Affect Disord 2015 May 21;184:116-122. doi: 10.1016/j.jad.2015.05.026. [Epub ahead of print]
110) E Scarr, MJ Millan, S Bahn, A Bertolino, CW Turck, S Kapur, HJ Möller, B Dean. Biomarkers for psychiatry: the journey from fantasy to fact, a report of the 2013 CINP Think Tank. Int J Neuropsychopharmacol. 2015 Apr 21. pii: pyv042. doi: 10.1093/ijnp/pyv042.
111) T Del Giudice, C Latapy, A Rampino, J Khlghatyan, B Gelao, T Quarto, G Rizzo, A Barbeau, C Lamarre, A Bertolino, G Blasi, JM Beaulieu. FXR1P is a GSK3β substrate regulating mood and emotionality. Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):E4610-9. doi: 10.1073/pnas.1506491112. Epub 2015 Aug 3.
112) D Vitucci, A Di Giorgio, F Napolitano, B Pelosi, G Blasi, F Errico, MT Attrotto, B Gelao, L Fazio, P Taurisano, A Di Maio, V Marsili, M Pasqualetti, A Bertolino#, A Usiello. Rasd2 modulates prefronto-striatal phenotypes in humans and "schizophrenia-like behaviors" in mice. #co-corresponding author Neuropsychopharmacology. 2016 Feb;41(3):916-27. doi: 10.1038/npp.2015.228. Epub 2015 Jul 31
113) M Colizzi, C Iyegbe, J Powell, G Blasi, A Bertolino, RM Murray and M Di Forti. Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case control study. NPJ Schizophrenia (2015) 1, 1-4, published online 18 November 2015
114) J Dukart, F Sambataro, A Bertolino. Accurate Prediction of Conversion to Alzheimer’s Disease using Imaging, Genetic and Neuropsychological Biomarkers. J Alzheimers Dis. 2015 Nov 23;49(4):1143-59. doi: 10.3233/JAD-150570
115) GL Ursini, T Cavalleri, L Fazio, T Angrisano, L Iacovelli, A Porcelli, G Maddalena, G Punzi, M Mancini, B Gelao, R Romano, R Masellis, F Calabrese, A Rampino, P Taurisano, A Di Giorgio, S Keller, L Tarantini, L Sinibaldi, T Quarto, T Popolizio, G Caforio, G Blasi, MA Riva, A De Blasi, L Chiariotti, V Bollati, A Bertolino. BDNF rs6265 methylation and genotype interact on risk for schizophrenia. Epigenetics, in press
116) G Pergola, P Di Carlo, I Andriola, S Torretta, MT Attrotto, L Fazio, A Raio, D Albergo, R Masellis, B Gelao, A Rampino, G Blasi, A Bertolino. Combined Effect of Genetic Variants in GRIN2B on Prefrontal Function during Working Memory Performance. Psychological Medicine (in press)
117) T Quarto, G Blasi, C Maddalena, G Viscanti, T Lanciano, E Soleti, I Mangiulli, P Taurisano, L Fazio, A Bertolino, A Curci. Association between ability emotional intelligence and left insula during social judgment of facial emotions. PLoS ONE, in press
118) H Cao*, A Bertolino*, H Walter*, M Schneider, A Schäfer, P Taurisano, G Blasi, L Haddad, O Grimm, K Otto, L Dixson, S Erk, S Mohnke, A Heinz, N Romanczuk-Seiferth, TW Mühleisen, M Mattheisen, SH Witt, S Cichon, M Noethen, M Rietschel, H Tost, Andreas Meyer-Lindenberg. Altered functional subnetwork during emotional face processing: a potential intermediate phenotype for schizophrenia, JAMA Psychiatry, in press
*equal contribution
119) LA Antonucci, P Taurisano, L Fazio, B Gelao, R Romano, T Quarto, A Porcelli, M Mancini, A Di Giorgio, G Caforio, G Pergola, T Popolizio, A Bertolino, G Blasi Association of familial risk for schizophrenia with thalamic and medial prefrontal functional connectivity during attentional control. Schizophrenia Research, in press
120) P Taurisano, LA Antonucci, L Fazio, A Rampino, R Romano, A Porcelli, R Masellis, M Colizzi, T Quarto, S Torretta, A Di Giorgio, G Pergola, A Bertolino, G Blasi. Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use. Cortex, 81 (2016) 231- 238
121) V Mazzola, G Arciero, L Fazio, T Lanciano, B Gelao, T Popolizio, P Vuilleumier, G Bondolfi, A Bertolino. What impact does an angry context have upon us? The effect of anger on functional connectivity of the right insula and superior temporal gyri. Front Behav Neurosci. 2016 Jun 6;10:109. doi: 10.3389/fnbeh.2016.00109. eCollection 2016.
122) A Rossi, S Galderisi, P Rocca, A Bertolino, A Mucci, P Rucci, D Gibertoni, E Aguglia, M Amore, I Andriola, A Bellomo, M Biondi, G Callista, A Comparelli, L Dell’Osso, M Di Giannantonio, A Fagiolini, C Marchesi, P Monteleone, C Montemagni, C Niolu, G Piegari, F Pinna, R Roncone, P Stratta, E Tenconi, A Vita, P Zeppegno, M Maj, Italian Network for Research on Psychoses. The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia. Results from the Italian Network for Research on Psychoses study. European Archives of Psychiatry and Clinical Neuroscience (in press)
123) G Pergola, S Trizio, P Di Carlo, P Taurisano, M Mancini, Nicola Amoroso, MA Nettis, I Andriola, G Caforio, T Popolizio, A Rampino, A Di Giorgio, A Bertolino, G Blasi. Grey Matter Volume Patterns in Thalamic Nuclei are Associated with Familial Risk for Schizophrenia. Schizophrenia Research, in press
124) A. Rampino, P Di Carlo, L. Fazio, G.L. Ursini, G. Pergola, C. De Virgilio, G. Gadaleta, G.M. Giordano, A. Bertolino, G. Blasi. Association of functional genetic variation in PP2A with prefrontal working memory processing. Behavioural Brain Research (in press)
125) Ankyrin-3 as a Molecular Marker of Early Life Stress and Vulnerability to Psychiatric Disorders. A Luoni, R Massart, V Nieratschker, Z Nemoda, G Blasi, M Gilles, SH Witt, MJ Suderman, SJ Suomi, A Porcelli, G Rizzo, L Fazio, S Torretta, A Rampino, A Berry, P Gass, F Cirulli, M Rietschel, A Bertolino, M Deuschle, M Szyf, M Riva. Translational Psychiatry (in press)
126) G. Breen, Q. Li, B.L. Roth, P. O`Donnell, M. Didriksen, R.Dolmetsch, P. O`Reilly, H. Gaspar, H. Manji, C. Huebel, J.R. Kelsoe, D. Malhotra, A. Bertolino, D. Posthuma, P. Sklar, S. Kapur, P.F. Sullivan, D.A. Collier, H.J. Edenberg: Translating Genomewide Association Findings into New Therapeutics for Psychiatry. Nature Neuroscience (in press)
127) L Fazio, G Logroscino, P Taurisano, G Amico, T Quarto, LA Antonucci, MR Barulli, M Mancini, B Gelao, L Ferranti, T Popolizio, A Bertolino, G Blasi. Prefrontal activity and connectivity with basal ganglia during performance of complex cognitive tasks is associated with apathy in healthy subjects. PLoS ONE (in press)
128) G Pergola, P Di Carlo, E D'Ambrosio, B Gelao, L Fazio, M Papalino, A Monda, G Scozia, B Pietrangelo, M Attrotto, JA Apud, Q Chen, VS Mattay, A Rampino, G Caforio, DR Weinberger, G Blasi and A Bertolino. DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia. Translational Psychiatry (2017) 7, e1006; doi:10.1038/tp.2016.253; published online 17 January 2017
129) J Dukart, F Sambataro, A Bertolino, Distinct role of striatal functional connectivity and dopaminergic loss in Parkinson’s symptoms. Frontiers in Aging Neuroscience, in press
130) S Sacchi, V De Novellis, G Paolone, T Nuzzo, M Iannotta, C Belardo, M Squillace, P Bolognesi, E Rosini, Z Motta, M Frassinetti, A Bertolino, L Pollegioni, M Morari, S Maione, F Errico, A Usiello. Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity. Scientific Reports, in press
131) T Nuzzo, S Sacchi, F Errico, S Keller, O Palumbo, E Florio, D Punzo, F Napolitano, M Copetti, M Carella, L Chiariotti, A Bertolino, L Pollegioni, A Usiello. Decreased free D-aspartate levels are linked to enhanced D-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients. NPJ Schizophrenia (in press) 132) T Moberget, N Trung Doan, D Alnæs, T Kaufmann, A Palomera, T Lagerberg, J Diedrichsen, E Schwarz, M Zink, P Kirsch, S Eisenacher, E Jonsson, H Fatouros-Bergman, L Flyckt, G Pergola, T Quarto, A Bertolino, D Barch, A Meyer-Lindenberg, I Agartz, O Andreassen, and L Tjelta Westlye. Cerebellar volume and cerebello-cerebral structural covariance in schizophrenia - a multi-site mega-analysis of 983 patients and 1349 healthy controls. Molecular Psychiatry, 2017;00:1-9
133) E. Walton, D. P. Hibar, T. G. M. van Erp, S. G. Potkin, R. Roiz-Santianez, B. Crespo-Facorro, P. Suarez-Pinilla, N. E. M. Van Haren, S. M. C. de Zwarte, R. S. Kahn, W.Cahn, N.T.Doan , K. N. Jørgensen, T. P. Gurholt, I. Agartz, O. A. Andreassen, L. T. Westlye, I. Melle, A. O. Berg, L. Mørch-Johnsen, A. Færden, L. Flyckt, H. Fatouros-Bergman, Karolinska Schizophrenia Project Consortium (KaSP), E. G. Jönsson, R. Hashimoto, H. Yamamori, M. Fukunaga, A. Preda, P. De Rossi, F. Piras, N. Banaj, V. Ciullo, G. Spalletta, R. E. Gur, R. C. Gur, D. H Wolf, T. D. Satterthwaite, L. M. Beard, I. E. Sommer, S. Koops, O. Gruber, A. Richter, B. Krämer, S. Kelly, G. Donohoe, C. McDonald, D. M. Cannon, A. Corvin, M. Gill, A. Di Giorgio, A. Bertolino, T. Nickson, S. Lawrie, H. C. Whalley, E. Neilson, V. D. Calhoun, P. M. Thompson, J. A. Turner, S. Ehrlich. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatrica Scandinavica, 2017; 1-9 134) U Bonati, S Holiga, N Hellbach, C Risterucci, T Bergauer, W Tang, P Hafner, A Thoeni, O Bieri, I Gerlach, A Marquet, O Khwaja, F Sambataro, A Bertolino, J Dukart, A Fischmann, D Fischer, C Czech. Longitudinal characterization of biomarkers for spinal muscular atrophy. Annals of Clinical and Transalational Neurology, first published April 11 2017
135) A Rossi, M Amore, S Galderisi, P Rocca, A Bertolino, E Aguglia, G Amodeo, A Bellomo, P Bucci, A Buzzanca, B Carpiniello, A Comparelli, L Dell’Osso, M di Giannantonio, M Mancini, C Marchesi, P Monteleone, C Montemagni, L Oldani, R Roncone, A Siracusano, P Stratta, E Tenconi, A Vignapiano, A Vita, P Zeppegno, M Maj. The complex relationship between self-reported 'personal recovery' and clinical recovery in schizophrenia. Schizophrenia Research, in press.
136) A Rampino, P Taurisano, G Fanelli, M Attrotto, S Torretta, LA Antonucci, G Miccolis, G Pergola, GL Ursini, G Maddalena, R Romano, P Di Carlo, R Masellis, P Pignataro, G Blasi, A Bertolino. A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans. Eur Neuropsychopharm, in press
137) E. Walton, D. P. Hibar, T. G. M. van Erp, S. G. Potkin, R. Roiz-Santianez, B. Crespo-Facorro, P. Suarez-Pinilla, N. E. M. Van Haren, S. M. C. de Zwarte, R. S. Kahn, W.Cahn, N.T.Doan , K. N. Jørgensen, T. P. Gurholt, I. Agartz, O. A. Andreassen, L. T. Westlye, I. Melle, A. O. Berg, L. Mørch-Johnsen, A. Færden, L. Flyckt, H. Fatouros-Bergman, Karolinska Schizophrenia Project Consortium (KaSP), E. G. Jönsson, R. Hashimoto, H. Yamamori, M. Fukunaga, A. Preda, P. De Rossi, F. Piras, N. Banaj, V. Ciullo, G. Spalletta, R. E. Gur, R. C. Gur, D. H Wolf, T. D. Satterthwaite, L. M. Beard, I. E. Sommer, S. Koops, O. Gruber, A. Richter, B. Krämer, S. Kelly, G. Donohoe, C. McDonald, D. M. Cannon, A. Corvin, M. Gill, A. Di Giorgio, A. Bertolino, T. Nickson, S. Lawrie, H. C. Whalley, E. Neilson, V. D. Calhoun, P. M. Thompson, J. A. Turner, S. Ehrlich. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychol Med. 2017 May 26:1-13. doi: 10.1017/S0033291717001283. [Epub ahead of print]
138) L Lo Bianco, MT Attrotto, S Torretta, R Masellis, A Rampino, E D’Ambrosio, AB Di Giorgio, L Ferranti, L Fazio, B Gelao, G Blasi, A Bertolino. Genetic variation is associated with RTN4R expression and working memory processing in healthy humans. Brain Research Bulletin, in press